| Citalopram-induced parkinsonian syndrome: case report. | |
| | |
MedLine Citation:
|
PMID: 21407001 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
OBJECTIVES: : To draw attention on citalopram as a possible cause of movement disorders. METHODS: : Case report of a patient with sudden-onset bilateral parkinsonian syndrome after administration of citalopram. RESULTS: : We describe a 67-year-old woman who developed sudden-onset bilateral rigidity, bradykinesia, resting and postural tremor, and typical parkinsonian gait 2 weeks after citalopram was administered. After discontinuation of citalopram, full recovery was observed, with a 4/108 score on the motor subscale of the Unified Parkinson Disease Rating Scale. Use of the Naranjo Adverse Drug Reactions Probability Scale indicated a probable (score of 8) adverse reaction of sudden-onset parkinsonism associated with citalopram consumption. CONCLUSION: : Physicians should be aware of possible parkinsonism as adverse reaction in patient taking citalopram because recognition and appropriate management can enable proper treatment and prevent serious adverse outcomes. |
| | |
Authors:
|
Vladimir Miletić; Maja Relja |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical neuropharmacology Volume: 34 ISSN: 1537-162X ISO Abbreviation: Clin Neuropharmacol Publication Date: 2011 Mar-Apr |
Date Detail:
|
Created Date: 2011-03-16 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7607910 Medline TA: Clin Neuropharmacol Country: United States |
Other Details:
|
Languages: eng Pagination: 92-3 Citation Subset: IM |
Affiliation:
|
Department of Neurology, School of Medicine, University of Zagreb, and University Hospital Centre Zagreb, Zagreb, Croatia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pregabalin in zolpidem dependence and withdrawal.
Next Document: Multidrug-resistant gram-negative infections.